Cell Counting Kit-8 (CCK-8) |
Catalog No.: GK10001 |
Cell Counting Kit-8 (CCK-8) is a ready-to-use one-bottle solution which offers a simple, rapid, reliable and sensitive measurement of cell viability and cytotoxicity of various chemicals.
Sample solution is provided at 25 µL, 10mM.
- Nature 610.7931 (2022)366-372.PMID:36198801
- Eur Rev Med Pharmaco 23.5 (2019)1947-1956.
- J Pharm Pharmacol 71(9), 1412-1420.PMID:31282010
- Adv Funct Mater 29.50 (2019)1906690.
- Biomed Pharmacother 122 (2020)109690.
- Phytother Res 34.4 (2020)836-845.
- J Membrane Biol (2019)1-13.
- J Cancer 11.5 (2020)1162-1169.
- Cell Mol Biol Lett 24.1 (2019)1-14.
- Stem Cell Res Ther 10.1 (2019)1-14.
- J Int Med Res (2019)PMID:31891283
- Mater Express 10.1 (2020)102-111.
- Drug Dev Res 81.4 (2020)437-443.PMID:31904108
- Transplant Proc (2020)52(1)398-405.PMID:31928781
- Mater Res Express 7.2 (2020)025401.
- Mol Ther-Nucl Acids (2020)
- J Exp Clin Canc Res 39.1 (2020)31.
- J Cell Mol Med (2020).
- Bosn J Basic Med Sci 20.3 (2020)357.PMID:31733641
- Front Pharmacol 11 (2020).
- Advanced Science1902938.
- Oncotargets Ther 13 (2020)2511.
- MedRxiv (2020).
- Spectrochim Acta A (2020)118387.
- Front Oncol 10 (2020).
- J King Saud Univ Sci (2020).
- J Ethnopharmacol (2020)112956.
- Life Sciences (2020)117793.
- BioRxiv (2020).
- Biomed Pharmacother 129 (2020)110315.PMID:32554246
- Cell Stress Chaperon (2020)1-14.PMID:32572784
- Acta Biomaterialia (2020).PMID:32629189
- Mol Cell Biochem (2020)1-14.PMID:32627113
- Exp Ther Med. 2020 Oct;20(4)3290-3300.
- Biomed Pharmacother 130 (2020)110566.PMID:32755793
- Mol Ther-Nucl Acids (2020).
- J Pharm Sci 75.10 (2020)505-509.
- Cell Cycle 19.17 (2020)2139-2147.
- Technol Cancer Res T 19 (2020)1533033820967472.
- Int J Mol Sci 21.21 (2020)8095.
- Oncotargets Ther 13 (2020)11301-11313.
- Pathol Res Pract (2020)153284.
- J Int Med Res 48.4 (2020)PMID:31891283
- Cancer Cell Int 20.1 (2020)1-14.
- Scientific Reports 10.1 (2020)1-11.PMID:33244088
- Toxicol Appl Pharm (2020)115361.
- Anal Cell Pathol (2020)6021602. PMID:33354489
- Cell Discovery 6.1 (2020)1-12.PMID:33349633
- Mol Cell Biochem (2021)1-14.PMID:33389498
- Mol Neurobiol (2021)1-15.PMID:33411316
- Front Pharmacol 11 (2021)2353.
- Chem Biodivers (2021).PMID:33624427
- Aging (Albany NY) 13.3 (2021)4482.PMID:33495411
- J Biol Chem (2021)100537.
- PLoS pathogens 17.3 (2021)e1009393.PMID:33684175
- Front Pharmacol 12 (2021)112.PMID:33762939
- Cancer Cell (2021).PMID:33740421
- Front Cell Dev Biol 8 (2021)1472.
- J Int Med Res 49.3 (2021)PMID:33730930
- Biomaterials (2021)120757.
- Front Cell Neurosci (2021).
- Open Medicine 16.1 (2021)558-569.
- Cell Death Dis 12.4 (2021)1-14.PMID:33859186
- Cancer Gene Ther (2021)1-12.PMID:33888871
- Phytomedicine (2021)153565.
- J Med Chem (2021).PMID:33872498
- Antimicrob Agents Ch (2021).PMID:33753340
- Chem Biodivers 18.4 (2021)e2001007.PMID:33624427
- Acta Diabetologica (2021)1-17.PMID:33907874
- Mol Biotechnol (2021)1-8.
- Toxicol Appl Pharm (2021)115559.PMID:33961903
- Compos Part B-Eng(2021)108984.
- Antimicrob Agents Ch 65.6 (2021).
- Diabet Metab Synd Ob 14 (2021)2255-2268.
- ACS Applied Bio Materials (2021).
- Exp Eye Res (2021)108642.
- Oncol Rep 46.1 (2021)1-12.PMID:34080652
- J Ethnopharmacol (2021)114275.PMID:34087404
- Front Pharmacol 12 (2021).PMID:34108880
- J Inflamm Res 14 (2021)2445-2463.
- HemaSphere 5.7 (2021).PMID:34136753
- Cancer Manag Res 13 (2021)4709-4723.
- Food Hydrocolloids (2021)106980.
- J Clean Prod (2021)128201.
- Oxid Med Cell Longev (2021)5549047.PMID:34257808
- Appl Entomol Zool (2021)1-14.
- BMC cancer 21.1 (2021)1-15.PMID:34130645
- J Inflamm Res 14 (2021)3523-3536.
- Cancer Cell Int 21.1 (2021)PMID:34281530
- Fiber Polym (2021)1-9.
- Biomed Res Int 2021 (2021).
- Front Pharmacol 12 (2021).PMID:34335241
- Dis Markers (2021).
- Nanomaterials 11.8 (2021)2008.
- Cell Death Dis 12.8 (2021)1-11.PMID:34365463
- Int J Mol Sci 22.16 (2021)8898.
- Front Cell Dev Biol 9 (2021).PMID:34447749
- Bioengineered 12.1 (2021)6687-6702.PMID:34516362
- Autophagy (2021)1-13.PMID:34517786
- Bioengineered 12.1 (2021)5985-5995.PMID:34477479
- Cells 10.9 (2021)2399.
- Nano Research (2021)1-8.
- Transl Oncol 14.12 (2021)101219.PMID:34555726
- Phytochem Lett 46 (2021)79-89.
- Oncol Rep 46.6 (2021)1-12.PMID:34643248
- Bioengineered 12.1 (2021)8698-8708.PMID:34697986
- Japanese J Gstro Hepato 7.7 (2021)1-55.
- J Appl Toxicol (2022)42(5)830-840.PMID:34708435
- Carbohyd Polym (2021)118869.
- Adv Clin Exp Med (2021).PMID:34329545
- BMC cancer 21.1 (2021)1-16.PMID:34740322
- PeerJ 9 (2021)e11482.
- Am J Transl Res 13.10 (2021)11255.PMID:34786056
- Lab Invest 102.4 (2022)411-421.PMID:34775495
- Bioengineered (2021)12(2)11936-11946.PMID:34784841
- Tissue and Cell 74 (2022)101680.PMID:34808429
- Inflammation (2021)1-15PMID:34792688
- Bioengineered 12.2 (2021)11451-11460.PMID:34895055
- Front Cell Dev Biol (2021)2721.PMID:34676217
- Int J Mol Sci 22.21 (2021)11893.PMID:34676217
- Aging (Albany NY) 13.17 (2021)21712.PMID:34518442
- Adv Healthc Mater2102395.PMID:34874119
- Nano Today 41 (2021)101326.
- J Asian Nat Prod Res (2021)1-8.PMID:34935551
- Exp Ther Med 23.2 (2022)1-9.
- Exp Ther Med (2022)23(2)158.PMID:35069839
- Reprod Sci (2022)1-14.PMID:34981461
- J Exp Clin Canc Res 41.1 (2022)1-15.PMID:34980201
- Bioengineered 13.1 (2022)1518-1529.PMID:34986734
- Bio-Des Manuf (2022)1-13.
- Bioengineered 13.1 (2022)455-468.PMID:34967265
- J Mol Neurosci (2022)1-8.PMID:35023001
- Phytochem Lett 47 (2022)174-179.
- Hypertens Res (2022)1-15.PMID:35082376
- Transl Cancer Res 11.1 (2022)207.
- Tissue and Cell (2022)101750.
- Pharmacol Res (2022)106112.
- Thoracic Cancer (2022).PMID:35098684
- Cell Cycle (2022)1-16.PMID:35100080
- Int J Mol Med 49.3 (2022)1-11.PMID:35014672
- Nano Today 43 (2022)101416.
- Cancer Gene Ther (2022)1-12.PMID:35115683
- Cell Journal 24.1 (2022)15-21.PMID:35182060
- Chem Biol Drug Des (2022)PMID:35184389
- Ecotox Environ Safe 233 (2022)113315.PMID:35189521
- Cell Death Discov 8.1 (2022)1-10.PMID:35220396
- BioRxiv (2022).
- Bioengineered 13.3 (2022)6650-6664.PMID:35230214
- Bioengineered 13.3 (2022)6807-6818.PMID:35246020
- Cell Death Dis 13.3 (2022)1-15.PMID:35288538
- Int Immunopharmacol 107 (2022)108695.PMID:35305385
- Front Oncol (2022)1087.
- Int J Gen Med 15 (2022)3199-3213.
- Front Oncol 12 (2022).PMID:35321435
- Oncol Lett 23.5 (2022)1-8.
- J Cancer 13.6 (2022)1808-1819.
- Virus Res (2022)198748.PMID:35304133
- ACS Appl Mater Inter (2022).PMID:35344348
- Int J Gen Med 15 (2022)3199.PMID:35342302
- Ann Hepatol (2022)100700.PMID:35338010
- Bioengineered 13.4 (2022)9145-9155.
- Int Immunopharmacol 108 (2022)108742.PMID:35378447
- Cell Biol Toxicol (2022)1-16.PMID:35348966
- Clin Cosmet Investig Dent 14 (2022)87.
- Bioengineered 13.4 (2022)10335-10349.PMID:35435110
- Curr Pharm Biotechno (2021).PMID:34463226
- Clin Cosmet Investig Dent 14 (2022)87.PMID:35411190
- Front Nutr 9 (2022).PMID:35419394
- Int J Mol Sci 23.8 (2022)4128.
- BMC cancer 22.1 (2022)1-14.PMID:35387643
- Clin Epigenetics 14.1 (2022)1-12.PMID:35414117
- Front Oncol 12 (2022)770628-770628.PMID:35372056
- Chem Biol Drug Des (2022).PMID:35184389
- Mater Today Bio (2022)100264.PMID:35517578
- Cell Journal 24.1 (2022)15.PMID:35182060
- Front Pharmacol 13 (2022)899775.
- Front Cell Infect Mi (2022)423.
- J Oncol 2022.PMID:35518787
- Oncogenesis 11.1 (2022)1-14.PMID:35487890
- Int J Biol Macromol (2022).PMID:35561854
- J Ethnopharmacol (2022)115360.
- Clin Transl Disc 2.2 (2022)e49.
- Human Cell (2022)1-19.PMID:35581525
- Cytotechnology (2022)1-12.
- Exp Ther Med 24.1 (2022)1-10.
- Oncol Rep 48.1 (2022)1-12.PMID:35593307
- Bioengineered 13.5 (2022)11987-12002.PMID:35603556
- Phytomedicine (2022)154199.
- NeuroReport 33.10 (2022)413-421.PMID:35623086
- Molecular Biotechnology (2022)1-9.PMID:35639278
- Foods 11.11 (2022)1575.
- J Cell Mol Med (2022).PMID:35656815
- Invest Ophth Vis Sci 63.6 (2022)13-13.PMID:35695808
- Oxid Med Cell Longev 2022 (2022).
- Brain Research Bulletin (2022).PMID:35738501
- Cell Mol Life Sci 79.7 (2022)1-17.PMID:35751755
- Free Radical Bio Med (2022).PMID:35787451
- Metab Brain Dis (2022)1-14.PMID:35779150
- Mater Today Adv 15 (2022)100271.
- Front Cell Dev Biol 10 (2022).PMID:35592246
- Transl Cancer Res 11.6 (2022)1781.PMID:35836521
- Biomater Sci-UK (2022).PMID:35815806
- Dis Markers 2022 (2022).
- Carbohyd Polym (2022)119878.
- Phytomedicine (2022)154330.
- J Oncol 2022 (2022).
- Oxid Med Cell Longev 2022 (2022)
- Pharm Biol 60.1 (2022)1436-1448.
- Dis Markers 2022 (2022).
- Discov Oncol 13.1 (2022)1-8.
- Int J Mol Sci 23.16 (2022)9014.
- Free Radical Bio Med (2022).PMID:35985562
- Int J Biol Macromol (2022).PMID:35970372
- Viruses 14.8 (2022)1783.
- J Biochem Mol Toxice23200.PMID:35997646
- Journal of Oncology 2022 (2022).
- Mol Neurobiol.PMID:36083519
- Environ Sci Technol (2022).PMID:36099323
- Dis Markers. (2022)PMID:35845132
- Life Sci (2022)120925.PMID:36057399
- J Nanobiotechnol 20.1 (2022)1-20.PMID:36123708
- Oxid Med Cell Longev 2022 (2022).PMID:36120596
- Biomolecules 12.9 (2022)1283.PMID:36139122
- Molecules 27.16 (2022)5337.
- Cancers 14.19 (2022)4645.
- Phytother Res (2022).
- Mol Immunol 152 (2022)27-34.PMID:36244215
- J Exp Clin Canc Res 41.1 (2022)1-15.PMID:36199122
- Bba-Mol Basis Dis (2022)166571.PMID:36244542
- Neurotox Res (2022)1-7.PMID:36223054
- J Oncol 2022 (2022).PMID:36213831
- Pharmaceutics 14.10 (2022)2157.
- Mol Carcinogen (2022).PMID:36222184
- Biomaterials Advances (2022)213165.
- Ecotox Environ Safe 247 (2022)114250.PMID:33421461
- Cancers 14.21 (2022)5218.
- J Agr Food Chem (2022).
- Int J Biochem Cell B (2022)106317.PMID:36283586
- Int Immunopharmacol 113 (2022)109342.PMID:36327871
- Int J Biol Macromol (2022).PMID:36283555
- Life Sciences (2022)121092.PMID:36279968
- J oncol 2022 (2022).PMID:36385962
- Cells 11.22 (2022)3580.
- Metab brain dis (2022)1-13.PMID:36445630
- Mol cell toxicol (2022)1-11.
- Histol histopathol (2022)18551-18551.PMID:36416408
- J cell physiol (2022).PMID:36436184
- Int J Biochem Cell B 153 (2022)106317.PMID:36283586
- J agr food chem (2022).PMID:36472370
- Mol immunol 153 (2023)126-134.PMID:36495817
- Bmc med genomics 15.1 (2022)1-19.PMID:36503492
- Apoptosis (2022)1-18.PMID:36482019
- Dis markers 2022 (2022).PMID:35968506
- Experimental Neurology 359 (2023)114266.PMID:36336032
- ACS Applied Bio Materials (2023).PMID:36603189
- Mater Today Chem 27 (2023)101331.
- Int J Mol Sci 24.2 (2023)1243.
- Biomark Res 11.1 (2023)1-19.PMID:36611218
- Biomed Pharmacother 158 (2023)114118.PMID:36527845
- Aquaculture 564 (2023)739060.
- Sci Rep-Uk 13.1 (2023)1-10.PMID:36611103
- Exp Ther Med 25.2 (2023)1-10.
- Drug Develop Res.
- Colloid Surface BPMID:36621177
- Sensor Actuat B-Chem
- Oxid Med Cell Longev(2023)
- Brain Behav Immun (2023)PMID:36754245
- Thoracic Cancer (2023)PMID:36737402
- Int J Pept Res Ther 29.2 (2023)19.
- Acta Biomaterialia 157 (2023)PMID:36481504
- LiverInternational (2023)PMID:36737842
- J Ethnopharmacol (2023)PMID:36746295
- Cell Mol Life Sci 80.3 (2023)PMID:36763212
- Pharmacology (2023)PMID:36724745
- Animal Biotechnology (2023)PMID:36756956
- Tissue CellPMID:36565506
- Poultry Sci
- Pharmacol ResPMID:36410674
- Mol Med
- Eur J Pharm BiopharmPMID:36702198
- J Agr Food Chem (2023)PMID:36634077
- J-Inflamm-Res2023,1045-1057
- View-China2023,20220052
- Redox-Biol2023;102663PMID:36924682
- Biotechnol-Genet-Eng(2023)1-17PMID:36946780
- Mol-Cell-Biochem(2023)1-11PMID:36939994
- J-Adv-Res(2023)PMID:36933884
- J-Neuroinflamm20.1(2023)1-16PMID:36944954
- Sci-Total-Environ(2023)162942PMID:36940749
- Chinese-Med-J-Peking(2023)10-1097PMID:36939243
- Int-J-Mol-Sci24.7(2023)6279
- Biomed-Pharmacother162(2023)114602PMID:37018993
- Cancer-Commun(2023)PMID:37005481
- Biotechnol-Genet-Eng(2023)1-15PMID:37018431
- Chinese-Med-J-Peking2023,136(5);556-564PMID:36939243
- Chinese-Med-J-Peking2023,136(5);556-564PMID:36939243
- Environ-Toxicol(2023)PMID:37052456
- N-S-Arch-Pharmacol(2023),1-13PMID:37052642
- Front-Oncol2023,13PMID:36959804
- Phytother-Res2023PMID:37086359
- The-FASEB-Journal,2023,37(5),e22935PMID:37086094
- Bioscience-Rep,2023,BSR20230028PMID:37083601
- J-Dermatol-Sci,2023,109(2),52-60PMID:36858850
- Front-Immunol,14-(2023)PMID:37006248
- Bba-Mol-Basis-Dis(2023),166725PMID:37127173
- Neurochem-Res-(2023),1-14PMID:37127800
- Curr-Issues-Mol-Biol2023,45(5)4017-4034
- Biochem-Genet2023,1-18PMID:37148331
- N-S-Arch-Pharmacol2023,1-13PMID:37160483
- J-Thorac-Dis2023,15(4),2199
- J-Gastroenterol2023,1-14PMID:37150773
- Ceram-Int-(2023)
- Biochem-Pharmacol-(2023),115592PMID:37196680
- Colloid-Surface-B,2023,-113364
- Oncol-Lett,-2023,-26(1),-1-17
- Int-J-Chronic-Obstr,-2023,-919-932PMID:37229441
- Adv-Funct-Mater,-2023,-2214998
Related Biological Data

Related Biological Data

Related Biological Data

Cell Number Determination
1. Inoculate cell suspension (100 μL/well) in a 96-well plate. Pre-incubate the plate in a humidified incubator (e.g., at 37°C, 5% CO2).
2. Add 10 μL of the CCK8 solution to each well of the plate. Be careful not to introduce bubbles to the wells, since they interfere with the O.D. reading.
3. Incubate the plate for 1 - 4 hours in the incubator.
4. Measure the absorbance at 450 nm using a microplate reader.
Cell Proliferation and Cytotoxicity Assay
1. Seed cells in a 96-well plate at a density of 103-104 cells/well in 100 μL of culture medium to be tested. Culture the cells in a CO2 incubator at 37°C for 24 hours.
2. Add various concentrations of substances to be tested to the plate.
3. Incubate the plate for an appropriate length of time (e.g., 6, 12, 24 or 48 hours) in the incubator.
4. Add 10 μL of CCK8 solution to each well of the plate using a repeating pipettor. Be careful not to introduce bubbles to the wells, since they interfere with the O.D. reading.
5. Incubate the plate for 1 - 4 hours in the incubator.
6. Before reading the plate, it is important to mix gently on an orbital shaker for 1 minute to ensure homogeneous distribution of color.
7. Measure the absorbance at 450 nm using a microplate reader.
Data Analysis
There are several ways to do statistical analysis. You can choose to use O.D. values or cell numbers. We offer one of them.
Cell viability (%) = [(As-Ab) / (Ac-Ab)] × 100
Inhibition rate (%) = [(Ac-As) / (Ac-Ab)] × 100
As = absorbance of the experimental well (absorbance of cells, medium, CCK8 and wells of the test compound).
Ab = blank well absorbance (absorbance of wells containing medium and CCK8).
Ac = control well absorbance (absorbance of wells containing cells, medium and CCK8).
Making a standard curve
1. The cell counting plate counts the number of cells in the cell suspension.
2. Using the medium, the cell suspension is diluted to a concentration gradient, usually requiring 5-7 concentration gradients, several replicate wells per group. Then inoculate the cells. (Note the number of cells per well. If you are diluting the cell suspension in a tube, carefully mix the cells again before adding the wells to the plate. The volume of the cell suspension in each well should be the same.)
3. Incubate until the cells are adherent (usually 2-4 hours), then add 10 μl of CCK8 per 100 μl of medium. Incubation was continued for 1-4 hours, and the absorbance at 450 nm was measured with a microplate reader. Make a standard curve with the number of cells as the X-axis coordinate and the O.D. value as the Y-axis coordinate.
The number of cells of the sample to be tested can be determined based on the curve. A prerequisite for using this standard curve is that the culture conditions are the same.
Precautions
1. Make sure the drug and CCK8 are evenly distributed in the medium.
2. The more cells proliferate, the darker the color; the stronger the cytotoxicity, the lighter the color.
3. For adherent cells, at least 1000 cells per well (100 μl medium). For leukocytes, at least 2500 cells per well (100 μl medium) are required due to their low sensitivity. The recommended 96-well plate has a maximum cell count of 25,000 per well. If the test is performed using a 24-well or 6-well plate, calculate the corresponding number of cells per well and adjust the volume of CCK8 to 10% of the total liquid volume per well.
4. Since the CCK8 assay is based on dehydrogenase activity in living cells, conditions or chemicals that affect dehydrogenase activity may result in a difference between the actual number of viable cells and the number of viable cells measured using CCK8.
5. WST-8 may react with a reducing agent to form WST-8 formazan. If a reducing agent (such as some antioxidants) is used, it will interfere with the test. If more reducing agent is present in the system to be tested, it is necessary to remove it.
6. After 2 hours of incubation, the background O.D. value is typically 0.1-0.2 units.
7. Be careful not to introduce air bubbles into the holes as they will interfere with the O.D. value.
8. If you want to sterilize the CCK8 solution, use a 0.2 μm membrane filter solution.
9. The incubation time will vary depending on the type and amount of cells in the well. Generally, leukocytes are less colored and may require longer incubation times (up to 4 hours) or large numbers of cells (~105 cells/well).
10. If there is high turbidity in the cell suspension, measure and subtract the O.D value of the sample at 600 nm or higher.
11. CCK8 cannot be used for cell staining.
12. The phenol red in the medium does not affect the experimental results. The absorbance of phenol red can be eliminated by subtracting the absorbance of the background in the blank hole during calculation, so it will not affect the detection.
13. The toxicity of CCK8 is very low. After the CCK8 assay is completed, the same cells can be used for other cell proliferation assays, such as crystal violet assay, neutral red assay or DNA fluorescence assay. (Unless the cells are extremely rare, it is not recommended.)
14. This kit can be used in E. coli but not in yeast cells.
15. Before reading the plate, you can mix gently on the shaker.
16. We recommend inoculation of cells in wells near the center of the plate. The medium in the outermost circle of holes is easily evaporated and can be filled with PBS, water or medium.
17. If you don't have a 450 nm filter. You can also use filters with absorbance between 430 and 490 nm, and 450 nm filters for optimum sensitivity.
18. Measure the absorbance at 450 nm. If you need to make a dual wavelength measurement, the absorbance at 650 nm can be determined as the reference wavelength.
19. The presence of metal ions in the drug may affect the sensitivity of CCK8. Lead chloride, iron chloride, and copper sulfate at a final concentration of 1 mM inhibit 5%, 15%, and 90% of the color reaction, reducing sensitivity. If the final concentration is 10 mM, it will be 100% inhibited.
Cell Counting Kit-8 (CCK-8) allows convenient assays using WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(
Cell Counting Kit-8 allows sensitive colorimetric assays for the determination of the number of viable cells in the proliferation and cytotoxicity assays. The detection sensitivity is higher than any other tetrazolium salts such as MTT, XTT or MTS.
Figure 1: Working mechanisms of Cell Counting Kit-8 (CCK-8).
Applications | 1) Cell proliferation determinations-the GlpBio Cell Counting Kit-8 (CCK-8) is water soluble, stable in culture, and non-toxic.
2) Cell viability assays-metabolic activity and dye generation changes in proportion to altered viability. 3) Cytokine assays-measure cytokine-induced proliferation. Cells can be recovered and expanded at the end of the study if desired. 4) Cytotoxicity assays-Cells death from cytotoxic chemicals has no effects on color development, only living cells convert the reagent into a colorimetric indicator. The reagent itself has negligible toxicity, and is generally safe for cells. |
Shipping | Ship with blue ice. |
Storage Conditions | Stored at 4°C protecting from light, and is stable for up to 12 months. Stored at -20°C protecting from light, and is stable for up to 2 years. |
Usage | For Research Use Only! Not For Use in Humans. |
CCK-8 | MTT | MTS | SRB |
Solubility | Water soluble | Indissolvable | Water soluble | Indissolvable |
Detection Wavelength | 450nm | 490nm | 450nm | 510nm |
Character | Liquid | Solid | Liquid | Liquid |
Usage | No need to prepare | Prepare the solutions | Use it right after it was ready | Prepared beforehand |
Need to redissolve or not | NO | Yes,by DMSO | No | Yes,by Tris-base solution |
Convenience | +++ | ++ | +++ | + |
Detection speed | +++ | + | ++ | + |
Repeatability | +++ | + | ++ | ++ |
Stability | ++ | + | + | +++ |
Average Rating: 5
(Based on Reviews and 280 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *